Skip to Main Content

Endocrinology & Metabolism Newsletter

January 2024

Dear Colleagues,

Happy 2024! As we settle into the new year, our section continues to develop new programs to advance interdisciplinary science at Yale, conduct cutting-edge research into mitochondrial metabolism and new medications for diabetes and obesity—among many other areas—and advocate on behalf of patients who seek access to novel treatments. Reflecting on the past year and looking ahead, we have many accomplishments to be proud of and many exciting projects underway.

As we continue to work with colleagues in New Haven and beyond to push the boundaries of discovery and patient care, please consider voting for Yale New Haven Hospital in U.S. News and World Report’s “Best Hospitals”—the survey will be available on Doximity next month.

Until then, I hope you enjoy reading a few of the many highlights from our section. As always, feel free to reach out to me at the email below to share your news or say hello.


John Wysolmerski, MD
Professor of Medicine (Endocrinology)
Section Chief, Endocrinology & Metabolism
Department of Internal Medicine, Yale School of Medicine

Latest News

Get RSS Feed